<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ostgathe C</submitter><funding>Universitätsklinikum Erlangen</funding><funding>Bundesministerium für Bildung und Forschung</funding><pagination>45</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11984285</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The use of sedative drugs in specialist palliative care is common but presents challenges due to specific medical, ethical, and legal considerations. There is little to no assistance for administering adequate sedative drug doses, ensuring accurate documentation before and during sedation, or managing ethically and legally challenging situations. In 2021, the SedPall study group published recommendations on the use of sedative drugs in palliative care. The German Association for Palliative Medicine endorsed the dissemination of the recommendations nationwide. However, disseminating recommendations alone does not necessarily lead to changes in clinical practice. In the project "Development and piloting of a multi-modal intervention for the use of sedative drugs in special</pubmed_abstract><journal>Pilot and feasibility studies</journal><pubmed_title>Use of sedative drugs in specialist palliative care (iSedPall): a multi-modal intervention pilot study protocol.</pubmed_title><pmcid>PMC11984285</pmcid><funding_grant_id>01GY2020A-C</funding_grant_id><pubmed_authors>Bausewein C</pubmed_authors><pubmed_authors>Ostgathe C</pubmed_authors><pubmed_authors>Kremling A</pubmed_authors><pubmed_authors>Krauss SH</pubmed_authors><pubmed_authors>Schildmann E</pubmed_authors><pubmed_authors>Schneider M</pubmed_authors><pubmed_authors>Schildmann J</pubmed_authors><pubmed_authors>Jager C</pubmed_authors><pubmed_authors>Seifert A</pubmed_authors><pubmed_authors>Klein C</pubmed_authors><pubmed_authors>Heckel M</pubmed_authors><pubmed_authors>Kauzner S</pubmed_authors><pubmed_authors>Ziegler K</pubmed_authors><pubmed_authors>Bazata J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Use of sedative drugs in specialist palliative care (iSedPall): a multi-modal intervention pilot study protocol.</name><description>&lt;h4>Background&lt;/h4>The use of sedative drugs in specialist palliative care is common but presents challenges due to specific medical, ethical, and legal considerations. There is little to no assistance for administering adequate sedative drug doses, ensuring accurate documentation before and during sedation, or managing ethically and legally challenging situations. In 2021, the SedPall study group published recommendations on the use of sedative drugs in palliative care. The German Association for Palliative Medicine endorsed the dissemination of the recommendations nationwide. However, disseminating recommendations alone does not necessarily lead to changes in clinical practice. In the project "Development and piloting of a multi-modal intervention for the use of sedative drugs in special</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2025-07-05T03:04:27.27Z</modification><creation>2025-07-05T03:04:27.27Z</creation></dates><accession>S-EPMC11984285</accession><cross_references><pubmed>40211291</pubmed><doi>10.1186/s40814-025-01627-3</doi></cross_references></HashMap>